TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2021
Source ID
10.1016/j.jbc.2021.101162

Entities

People

  • Benjamin L. Bryson
  • Bryan M. Webb
  • Darcie D. Seachrist
  • Eduardo Williams-medina
  • Jessica R. Bobbitt
  • Lindsey J. Anstine
  • Ruth A Keri

Organizations

  • Case Comprehensive Cancer Center
  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense